(Q73949735)
English
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical
scientific article published on 01 October 1997
Statements
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor Therapy (English)
R Greil
H Hausmaninger
O Krieger
P Oppitz
M Stöger
J Klocker
M Neubauer
W Helm
J Pont
B Fazeny
M Hudec
I Simonitsch
T Radaszkiewicz